Literature DB >> 33864749

Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination.

Viktoria Muster1, Thomas Gary2, Reinhard B Raggam1, Albert Wölfler3, Marianne Brodmann1.   

Abstract

Entities:  

Year:  2021        PMID： 33864749     DOI： 10.1016/S0140-6736(21)00871-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Signaling COVID-19 Vaccine Adverse Events.

Authors:  Rave Harpaz; William DuMouchel; Robbert Van Manen; Alexander Nip; Steve Bright; Ana Szarfman; Joseph Tonning; Magnus Lerch
Journal:  Drug Saf       Date:  2022-06-23       Impact factor: 5.228

2.  Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19.

Authors:  Oscar M P Jolobe
Journal:  Am J Emerg Med       Date:  2021-05-23       Impact factor: 4.093

3.  Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination.

Authors:  Sean Platton; Andrew Bartlett; Peter MacCallum; Mike Makris; Vickie McDonald; Deepak Singh; Marie Scully; Sue Pavord
Journal:  J Thromb Haemost       Date:  2021-07-05       Impact factor: 16.036

4.  Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin.

Authors:  B Singh; A Kanack; A Bayas; G George; M Y Abou-Ismail; M Kohlhagen; M Christ; M Naumann; K Moser; K Smock; A Grazioli; D Murray; A Padmanabhan
Journal:  medRxiv       Date:  2021-09-24

5.  Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review.

Authors:  Usama Waqar; Shaheer Ahmed; Syed M H Ali Gardezi; Muhammad Sarmad Tahir; Zain Ul Abidin; Ali Hussain; Natasha Ali; Syed Faisal Mahmood
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

6.  COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia.

Authors:  Shyh Poh Teo
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

Review 7.  Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome.

Authors:  Paolo Gresele; Stefania Momi; Rossella Marcucci; Francesco Ramundo; Valerio De Stefano; Armando Tripodi
Journal:  Haematologica       Date:  2021-12-01       Impact factor: 9.941

Review 8.  Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism.

Authors:  Piotr Rzymski; Bartłomiej Perek; Robert Flisiak
Journal:  Vaccines (Basel)       Date:  2021-05-27

Review 9.  Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions.

Authors:  Kiran T Thakur; Arina Tamborska; Greta K Wood; Emily McNeill; David Roh; Imo J Akpan; Eliza C Miller; Alyssa Bautista; Jan Claassen; Carla Y Kim; Alla Guekht; Carlos A Pardo; Olajide Williams; David García-Azorín; Kameshwar Prasad; Erich Schmutzhard; Benedict D Michael; Sherry H-Y Chou; Andrea S Winkler; Tom Solomon; Mitchell S Elkind
Journal:  J Neurol Sci       Date:  2021-06-05       Impact factor: 3.181

10.  Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination.

Authors:  Thomas Gattringer; Paul Gressenberger; Thomas Gary; Albert Wölfler; Markus Kneihsl; Reinhard Bernd Raggam
Journal:  Stroke Vasc Neurol       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.